Skip to main content

Cancer-killing virus designer Vyriad raises $24.4 million

Vyriad Inc., a company that creates cancer-killing viruses, has raised $24.4 million as part of a planned $37.8 million Series B financing round.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.